These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6624181)

  • 1. [The effect of urea in a topical corticoid preparation on vasoconstriction].
    Früh H
    Z Hautkr; 1983 Aug; 58(16):1203-5. PubMed ID: 6624181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of 3 corticoid preparations with the vasoconstriction and erythema test].
    Früh H
    Z Hautkr; 1983 Mar; 58(5):317-23. PubMed ID: 6845798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Various vagaries of vasoconstriction.
    Burdick KH
    Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-frequency ultrasound sonophoresis to increase the efficiency of topical steroids: a pilot randomized study of humans.
    Maruani A; Boucaud A; Perrodeau E; Gendre D; Giraudeau B; Machet L
    Int J Pharm; 2010 Aug; 395(1-2):84-90. PubMed ID: 20472045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of dry skin with preparations containing carbamide].
    Rajka G
    Tidsskr Nor Laegeforen; 1974 Apr; 94(12):790. PubMed ID: 4830345
    [No Abstract]   [Full Text] [Related]  

  • 8. A qualitative estimate of the influence of halcinonide concentration and urea on the reservoir formation in the stratum corneum.
    Clarys P; Gabard B; Barel AO
    Skin Pharmacol Appl Skin Physiol; 1999; 12(1-2):85-9. PubMed ID: 10325587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plethysmographic recordings of skin pulses. VI. Further measurements of the vasoconstriction produced by corticosteroids.
    Thune P
    Acta Derm Venereol; 1972; 52(4):303-7. PubMed ID: 4115885
    [No Abstract]   [Full Text] [Related]  

  • 10. [Moisture retaining effect and tolerance of urea-containing Externa in neurodermatitis patients].
    Taube KM
    Hautarzt; 1992; 43 Suppl 11():30-2. PubMed ID: 1555941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. III. Vasoeffect of mineralocorticoids time slope of vasoconstriction influence of steroid concentration].
    Altmeyer P; Zaun H
    Arch Dermatol Forsch; 1974; 250(4):381-8. PubMed ID: 4447379
    [No Abstract]   [Full Text] [Related]  

  • 12. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N; Hebeda KM; de Bruijn HS; Star WM
    Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
    Brehm K; Maucher OM
    Arzneimittelforschung; 1972 Jun; 22(6):1038-9. PubMed ID: 5068352
    [No Abstract]   [Full Text] [Related]  

  • 14. [Improvement of skin moisture and skin texture with urea therapy].
    Puschmann M; Gogoll K
    Hautarzt; 1989; 40 Suppl 9():67-70. PubMed ID: 2807927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of admixture of commercially available corticosteroid ointments and/or creams on vasoconstrictor activity].
    Ohtani M; Yamada N; Takayama K; Kotaki H; Etoh T; Kariya S; Uchino K; Iga T
    Yakugaku Zasshi; 2002 Jan; 122(1):107-12. PubMed ID: 11828745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new type of topical corticoid. Principle and experimental activity control].
    Escande JP
    Nouv Presse Med; 1972 Jan; 1(3):181-2. PubMed ID: 5061528
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative bio-availability and activity of proprietary topical corticosteroid preparations: vasoconstrictor assays on thirty-one ointments.
    Barry BW; Woodford R
    Br J Dermatol; 1975 Nov; 93(5):563-71. PubMed ID: 1203181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An optoelectronic method for the evaluation of the cutaneous vasoconstriction and vasodilatation after topical application of different ointments (author's transl)].
    Blazek V; Wienert V
    Biomed Tech (Berl); 1980 Oct; 25(10):261-8. PubMed ID: 7448297
    [No Abstract]   [Full Text] [Related]  

  • 19. Irritant reactions from topical urea preparations used for dry skin. Advantages of a urea-free "Dead Sea salt" cream.
    Fisher AA
    Cutis; 1976 Dec; 18(6):761, 763, 767 passim. PubMed ID: 138571
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay.
    Woodford R; Barry BW
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):338-45. PubMed ID: 4208350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.